Page 161 - Orange Book Cumulative Supplement 10 October 2012

A - 24
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
LENALIDOMIDE - REVLIMID
N021880 001 5635517 Oct 04, 2019 DS U-1211
6045501 Aug 28, 2018 U-1210
6281230 Jul 24, 2016 U-1212
6315720 Oct 23, 2020 U-1210
6555554 Jul 24, 2016 DP U-1211
6561976 Aug 28, 2018 U-1210
6561977 Oct 23, 2020 U-1210
6755784 Oct 23, 2020 U-1210
6908432 Aug 28, 2018 U-1210
7189740 Apr 11, 2023 U-1215
7465800 Apr 27, 2027 DS DP
7968569 Oct 07, 2023 U-1216
8204763 Aug 28, 2018 U-1249
>A> 8288415 Jul 24, 2016 DS DP
LENALIDOMIDE - REVLIMID
N021880 002 5635517 Oct 04, 2019 DS U-1211
6045501 Aug 28, 2018 U-1210
6281230 Jul 24, 2016 U-1212
6315720 Oct 23, 2020 U-1210
6555554 Jul 24, 2016 DP U-1211
6561976 Aug 28, 2018 U-1210
6561977 Oct 23, 2020 U-1210
6755784 Oct 23, 2020 U-1210
6908432 Aug 28, 2018 U-1210
7189740 Apr 11, 2023 U-1215
7465800 Apr 27, 2027 DS DP
7968569 Oct 07, 2023 U-1216
8204763 Aug 28, 2018 U-1249
>A> 8288415 Jul 24, 2016 DS DP
LENALIDOMIDE - REVLIMID
N021880 003 5635517 Oct 04, 2019 DS U-1211
6045501 Aug 28, 2018 U-1210
6281230 Jul 24, 2016 U-1212
6315720 Oct 23, 2020 U-1210
6555554 Jul 24, 2016 DP U-1211
6561976 Aug 28, 2018 U-1210
6561977 Oct 23, 2020 U-1210
6755784 Oct 23, 2020 U-1210
6908432 Aug 28, 2018 U-1210
7189740 Apr 11, 2023 U-1215
7465800 Apr 27, 2027 DS DP
7855217 Nov 24, 2024 DS DP
7968569 Oct 07, 2023 U-1216
8204763 Aug 28, 2018 U-1249
>A> 8288415 Jul 24, 2016 DS DP